High Dose Versus Standard Dose of Ribavirin in Patients With Chronic Hepatitis C, Genotype 3

Clinical trial NCT00830609 · COMPLETED

Trial details

NCT number: NCT00830609
Sponsor: Dr. Conrado Fernandez
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Hepatitis C

Start date: 2008-11-01
Primary completion: 2011-09-01
Enrollment: 101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.